Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $20.29 and last traded at $19.94, with a volume of 438163 shares changing hands. The stock had previously closed at $21.76.
Analyst Upgrades and Downgrades
ACHC has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Guggenheim started coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. Barclays reduced their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Finally, KeyCorp dropped their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.
Check Out Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Stock Down 18.1%
The business has a fifty day moving average of $22.44 and a 200 day moving average of $28.30. The stock has a market cap of $1.64 billion, a price-to-earnings ratio of 8.78, a P/E/G ratio of 4.07 and a beta of 0.88. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The firm had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. During the same quarter in the prior year, the business earned $0.91 earnings per share. The company's revenue was up 9.2% on a year-over-year basis. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Treasurer of the State of North Carolina increased its position in Acadia Healthcare by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock worth $1,586,000 after purchasing an additional 250 shares during the period. Coldstream Capital Management Inc. increased its position in Acadia Healthcare by 4.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after purchasing an additional 303 shares during the period. Covestor Ltd increased its position in Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after purchasing an additional 310 shares during the period. Verdence Capital Advisors LLC grew its position in shares of Acadia Healthcare by 3.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company's stock worth $333,000 after buying an additional 465 shares during the period. Finally, PNC Financial Services Group Inc. grew its position in shares of Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock worth $202,000 after buying an additional 622 shares during the period.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.